跳至主要内容
临床试验/NL-OMON48498
NL-OMON48498已完成2 期

Stereotactic Arrhythmia Radiotherapy in the Netherlands no. 1 - STARNL-1 trial

Academisch Medisch Centrum0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >18 years
  • - Implanted ICD
  • - World Health Organization (WHO) / Eastern Cooperative Oncology Group (ECOG)
  • performance status grade 0-3 in the past 3 months (from fully active to
  • capable of limited self-
  • - At least 3 episodes of treated VT within the last 3 months
  • - Recurrence of VT after
  • o Failed or intolerance to at least one class 1 or class 3
  • anti-arrhythmic drug
  • o At least one catheter ablation procedure OR considered to be
  • unsuitable for a catheter
  • ablation procedure (e.g. no sufficient vascular access,
  • considered unfit to undergo
  • prolonged general anesthesia, comorbid conditions resulting in
  • unacceptable peri-
  • procedural risks)
  • - Able and willing to undergo all necessary evaluations, treatment and
  • follow-up for the study and
  • of follow-up thereafter
  • - Informed consent

排除标准

  • - Pregnancy
  • - History of radiation treatment in the thorax or upper abdominal region
  • - Interstitial pulmonary disease
  • - Renal insufficiency with a glomerular filtration rate <30ml/min
  • - Refusal or inability to provide informed consent or to undergo all necessary
  • evaluations,
  • treatment and follow-up for the study

研究者

相似试验